StAT-TB (Statin Adjunctive Therapy for TB): A Phase 2b Dose-finding Study of Pravastatin in Adults With Tuberculosis
Status:
Recruiting
Trial end date:
2022-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety, tolerability, and pharmacokinetics of
pravastatin adjunctive therapy when combined with the standard tuberculosis (TB) treatment
regimen in adults with TB.
Phase:
Phase 2
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Treatments:
Pravastatin Pyridoxal Pyridoxine Rifampin Vitamin B 6 Vitamin B Complex Vitamins